secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-06-24T11:45:56+00:00
Accession:  0001437749-26-021504
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical CEO Patrick Schnegelsberg steps down; Chairman Richard Fang named interim CEO
--------------------------------------------------------------------------------

- Patrick NJ Schnegelsberg resigned as CEO and board member effective June 18, 2026; departure not related to any disagreement.
- Board appointed Richard Fang, Ph.D., current Chairman, as Interim CEO effective June 18, 2026; he will serve until permanent successor found.
- Dr. Fang previously served as CEO from 2021 to 2023; founded Reach Surgical and has over 20 years med-tech experience.
- As Interim CEO, Dr. Fang will receive an annual salary of $400,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/pmi20260618_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-021504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer